A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Aceclidine/tropicamide (Primary)
- Indications Presbyopia
- Focus Therapeutic Use
- Sponsors Presbyopia Therapies
- 30 Oct 2017 Planned End Date changed from 2 Nov 2017 to 1 Apr 2018.
- 30 Oct 2017 Planned primary completion date changed from 2 Oct 2017 to 1 Apr 2018.
- 30 Jun 2017 New trial record